GLHRL Stock View

Global Longlife Hospital and Research Ltd
stock-view-header

icon -1.01 | -2.15
Market Cap ₹( Cr.)
493.50
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)

Stock View

Last Updated On.
25-Feb-2024
 

The average score for Global Longlife Hospital and Research Ltd stands at 3 against 5, three months back.

Global Longlife Hospital and Research Limited is a multispecialty hospital operator providing medical and allied services. The Company offers medical services across oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, gi medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include cvts, joint replacement and ortho, general surgery, onco surgery, gi surgery, neurosurgery and ear, nose and throat. Its radiology services include mammography, ct scan, x-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
50.02
100 DMA(₹)
46.57
200 DMA(₹)
45.04
52 Weeks Range
36.25     61.70

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required